John Woolcott

2.7k citations

73 papers · 2.0k indexed · 1 hit paper · h-index 17

Impact in

Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Physical Therapy, Sports Therapy and Rehabilitation top 1%
- Balance, Gait, and Falls Prevention

Papers in ⓘ

Rheumatology 30
- Rheumatoid Arthritis Research and Therapies 25
Hematology 14
- Autoimmune and Inflammatory Disorders Research 14

Co-authors: Carlo A. Marra (4 shared papers)Aslam H. Anis (5 shared papers)John M. Esdaile (2 shared papers)Kam Shojania (1 shared paper)Robert Offer (1 shared paper)Jacek A. Kopec (1 shared paper)John Brazier (1 shared paper)Lara Fallon (11 shared papers)
Journals: Annals of the Rheumatic Diseases (11 papers)Inflammatory Bowel Diseases (9 papers)Journal of Crohn s and Colitis (8 papers)The American Journal of Gastroenterology (7 papers)Arthritis Care & Research (3 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

John Woolcott

62 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons 2009 · 909 citations

Peers

Countries citing papers authored by John Woolcott

Since Specialization

Citations

This map shows the geographic impact of John Woolcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Woolcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Woolcott more than expected).

Fields of papers citing papers by John Woolcott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Woolcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Woolcott. The network helps show where John Woolcott may publish in the future.

Co-authors

The 25 scholars most cited alongside John Woolcott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Woolcott Line = papers co-authored together John Woolcott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons Archives of Internal Medicine ·John Woolcott Hit paper breakdown →	2009	909
2	A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis Social Science & Medicine ·Carlo A. Marra, John Woolcott, Jacek A. Kopec, Kam Shojania, Robert Offer, John Brazier, John M. Esdaile, Aslam H. Anis	2004	333
3	Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data Annals of the Rheumatic Diseases ·Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel M. Kremer, Jeffrey D. Greenberg, Wendi Malley, Alina Onofrei, Keith S. Kanik, Daniela Graham, Cunshan Wang, Carol A. Connell, Hernán Valdez, Manfred Hauben, Eric Hung, Ann Madsen, Thomas V. Jones, Jeffrey R. Curtis	2020	153
4	FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS Annals of the Rheumatic Diseases ·Maxime Dougados, Désirée van der Heijde, Clifton O. Bingham, Peter C. Taylor, Lara Fallon, John Woolcott, Y. Brault, L. Wang, M. Kessouri	2020	43
5	Does physical activity reduce seniors' need for healthcare?: a study of 24 281 Canadians British Journal of Sports Medicine ·John Woolcott, Maureen C. Ashe, William C. Miller, Peilin Shi, Carlo A. Marra	2009	42
6	Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry Inflammatory Bowel Diseases ·Manasi Agrawal, Erica J. Brenner, Xian Zhang, Irene Modesto, John Woolcott, Ryan C. Ungaro, Jean‐Frédéric Colombel, Michael D. Kappelman	2020	41
7	Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View Inflammatory Bowel Diseases ·Marla C. Dubinsky, Kenji Watanabe, Pauliina Molander, Laurent Peyrin‐Biroulet, Michele Rubin, Gil Melmed, J. Jasper Deuring, John Woolcott, Joseph C. Cappelleri, Kathy Steinberg, Susan J. Connor	2021	32
8	Lowering Generic Drug Prices Medical Care ·Aslam H. Anis, Daphne Guh, John Woolcott	2003	29
9	Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians Inflammatory Bowel Diseases ·David T. Rubin, Ailsa Hart, Remo Panaccione, Alessandro Armuzzi, Ulla Suvanto, J. Jasper Deuring, John Woolcott, Joseph C. Cappelleri, Kathy Steinberg, Laura Wingate, Stefan Schreiber	2020	25
10	Cost‐Utility Analysis of a Multidisciplinary Strategy to Manage Osteoarthritis of the Knee: Economic Evaluation of a Cluster Randomized Controlled Trial Study Arthritis Care & Research ·Carlo A. Marra, Maja Grubisić, Jolanda Cibere, Kelly Grindrod, John Woolcott, Louise Gastonguay, John M. Esdaile	2013	25
11	Potential cost-effectiveness of annual influenza immunization for infants and toddlers: Experience from Canada Vaccine ·Danuta M. Skowronski, John Woolcott, Sam Tweed, R C Brunham, F MARRA	2006	24
12	The cost of fall related presentations to the ED: A prospective, in-person, patient-tracking analysis of health resource utilization Osteoporosis International ·John Woolcott, Karim M. Khan, Suzana Mitrovic, Aslam H. Anis, Carlo A. Marra	2011	22
13	Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis The Journal of Rheumatology ·Paul Emery, Bonnie Vlahos, Piotr Szczypa, Mazhar Thakur, Heather Jones, John Woolcott, Paul V. Santos Estrella, Catherine Rolland, Allan Gibofsky, Gustavo Citera, Sargunan Sockalingam, Lisa Marshall	2019	19
14	Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years ACR Open Rheumatology ·Janet Pope, Edward Keystone, Shahin Jamal, Lisy Wang, Lara Fallon, John Woolcott, Irina Lazariciu, Douglass Chapman, Boulos Haraoui	2019	18
15	Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years Lara D. Veeken ·Janet Pope, Louis Bessette, Niall Jones, Lara Fallon, John Woolcott, David Gruben, Michael G. Crooks, David Gold, Boulos Haraoui	2019	17
16	Safety and cost benefit of same-day discharge after percutaneous coronary intervention The American Journal of Cardiology ·Shailesh Khatri, John G. Webb, Ronald G. Carere, Aslam Amis, John Woolcott, Sanjay Chugh, Karin H. Humphries	2002	16
17	A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of??Hypertension with Left Ventricular Hypertrophy PharmacoEconomics ·Aslam H. Anis, Huiying Sun, Sonia R. Singh, John Woolcott, Bohdan Nosyk, Marc Brisson	2006	16
18	<p>Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making</p> Patient Preference and Adherence ·Peter C. Taylor, Neil Betteridge, T. Michelle Brown, John Woolcott, Alan Kivitz, Cristiano A. F. Zerbini, Diane Whalley, Oyebimpe Olayinka-Amao, Connie Chen, Palle Dahl, Darío Ponce de León, David Gruben, Lara Fallon	2020	15
19	Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis Inflammatory Bowel Diseases ·William J. Sandborn, Alessandro Armuzzi, Giuseppina Liguori, Peter M. Irving, Ala I. Sharara, Rajiv Mundayat, Nervin Lawendy, John Woolcott, Silvio Danese	2021	15
20	Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients Arthritis & Rheumatology ·Christina Charles‐Schoeman, Roy Fleischmann, Eduardo Mysler, Maria Greenwald, Steven R. Ytterberg, Gary G. Koch, Deepak L. Bhatt, Cunshan Wang, Ted R. Mikuls, All‐shine Chen, Carol A. Connell, John Woolcott, Sujatha Menon, Yan Chen, Kristen Lee, Zoltán Szekanecz	2024	13

About John Woolcott

John Woolcott is a scholar working on Rheumatology, Hematology, Hepatology, Genetics and Genetics, having authored 73 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (26 papers), Rheumatoid Arthritis Research and Therapies (25 papers), Autoimmune and Inflammatory Disorders Research (14 papers), Microscopic Colitis (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Biosimilars and Bioanalytical Methods (10 papers), Liver Diseases and Immunity (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Geriatrics and Gerontology (354 citations), Physical Therapy, Sports Therapy and Rehabilitation (368 citations), Rheumatology (375 citations), Psychiatry and Mental health (316 citations) and Family Practice (31 citations). John Woolcott has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Carlo A. Marra, Aslam H. Anis, John M. Esdaile, Kam Shojania, Robert Offer, Jacek A. Kopec, John Brazier, Lara Fallon, Daphne Guh and Cunshan Wang. Their work appears in journals such as Annals of the Rheumatic Diseases, Inflammatory Bowel Diseases, Journal of Crohn s and Colitis, The American Journal of Gastroenterology and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact